Charles River Laboratories Gross Profit 2010-2024 | CRL

Charles River Laboratories annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Charles River Laboratories gross profit for the quarter ending June 30, 2024 was $0.354B, a 11.35% decline year-over-year.
  • Charles River Laboratories gross profit for the twelve months ending June 30, 2024 was $1.424B, a 7.84% decline year-over-year.
  • Charles River Laboratories annual gross profit for 2023 was $1.503B, a 2.73% increase from 2022.
  • Charles River Laboratories annual gross profit for 2022 was $1.463B, a 9.59% increase from 2021.
  • Charles River Laboratories annual gross profit for 2021 was $1.335B, a 24.32% increase from 2020.
Charles River Laboratories Annual Gross Profit
(Millions of US $)
2023 $1,503
2022 $1,463
2021 $1,335
2020 $1,074
2019 $958
2018 $840
2017 $701
2016 $644
2015 $531
2014 $473
2013 $395
2012 $392
2011 $402
2010 $385
2009 $423
Charles River Laboratories Quarterly Gross Profit
(Millions of US $)
2024-06-30 $354
2024-03-31 $345
2023-12-31 $364
2023-09-30 $362
2023-06-30 $399
2023-03-31 $378
2022-12-31 $399
2022-09-30 $370
2022-06-30 $357
2022-03-31 $337
2021-12-31 $347
2021-09-30 $337
2021-06-30 $342
2021-03-31 $308
2020-12-31 $300
2020-09-30 $289
2020-06-30 $232
2020-03-31 $252
2019-12-31 $262
2019-09-30 $246
2019-06-30 $238
2019-03-31 $212
2018-12-31 $226
2018-09-30 $216
2018-06-30 $216
2018-03-31 $181
2017-12-31 $167
2017-09-30 $177
2017-06-30 $185
2017-03-31 $171
2016-12-31 $177
2016-09-30 $156
2016-06-30 $170
2016-03-31 $141
2015-12-31 $141
2015-09-30 $138
2015-06-30 $133
2015-03-31 $120
2014-12-31 $120
2014-09-30 $118
2014-06-30 $126
2014-03-31 $109
2013-12-31 $88
2013-09-30 $100
2013-06-30 $103
2013-03-31 $104
2012-12-31 $91
2012-09-30 $93
2012-06-30 $104
2012-03-31 $104
2011-12-31 $101
2011-09-30 $93
2011-06-30 $106
2011-03-31 $103
2010-12-31 $94
2010-09-30 $91
2010-06-30 $101
2010-03-31 $99
2009-12-31 $94
2009-09-30 $107
2009-06-30 $114
2009-03-31 $108
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00